Defendant Name: Tanya R. Carro, CPA

Defendant Type: Individual

Initial Case Details

Legal Case Name In the Matter of Tanya R. Carro, CPA
First Document Date 31-Jul-2020
Initial Filing Format Administrative Action
File Number 3-19902
Allegation Type Issuer Reporting and Disclosure
AAER 4155

Affiliations

Violations Alleged

Securities Act
• Sec 17(a)(2)
• Sec 17(a)(3)
Other
• Rule 13b2-1 Exchange Act; Rule 100(b) Regulation G

Related Violations Alleged

Tanya R. Carro, CPA is alleged to have caused Bausch Health Companies, Inc.'s violation of Rule 12b-20 of the Exchange Act.
Tanya R. Carro, CPA is alleged to have caused Bausch Health Companies, Inc.'s violation of Sec 13(a) of the Exchange Act.
Tanya R. Carro, CPA is alleged to have caused Bausch Health Companies, Inc.'s violation of Rule 13a-1 of the Exchange Act.
Tanya R. Carro, CPA is alleged to have caused Bausch Health Companies, Inc.'s violation of Rule 13a-11 of the Exchange Act.
Tanya R. Carro, CPA is alleged to have caused Bausch Health Companies, Inc.'s violation of Rule 13a-13 of the Exchange Act.
Tanya R. Carro, CPA is alleged to have caused Bausch Health Companies, Inc.'s violation of Sec 13(b)(2)(A) of the Exchange Act.
Tanya R. Carro, CPA is alleged to have caused Bausch Health Companies, Inc.'s violation of Sec 13(b)(2)(B) of the Exchange Act.

Resolutions

Bars:
First Resolution Date 31-Jul-2020

Related Documents:

33-10812 31-Jul-2020 Administrative Proceeding
Order Instituting Public Administrative and Cease-and-Desist Proceedings Pursuant to Section 8A of the Securities Act of 1933, Sections 4C and 21C of the Securities Exchange Act of 1934, and Rule 102(e) of the Commission's Rules of Practice, Making Findings, and Imposing Remedial Sanctions and a Cease-and-Desist Order

Related Actions:

In the Matter of Valeant Pharmaceuticals International, Inc., n/k/a Bausch Health Companies Inc.
Bausch Health Companies, Inc.
In the Matter of J. Michael Pearson
J. Michael Pearson
In the Matter of Howard B. Schiller
Howard B. Schiller